GSK: Post-Pivot Buoyancy Set To Continue After Strong 2025 (Upgrade)
Source: SeekingAlpha
2026-02-17 12:10:05 ET
Investment Overview
The last time I wrote about GSK plc ( GSK ) for Seeking Alpha, it was late September, and I was covering the news that its CEO since 2017, Emma Walmsley, was stepping away from the role to be replaced by the current Chief Commercial Officer ("CCO") Luke Miels....
Read the full article on Seeking Alpha
For further details see:
GSK: Post-Pivot Buoyancy Set To Continue After Strong 2025 (Upgrade)
GlaxoSmithKline Plc
NASDAQ: GLAXF
GLAXF Trading
0.0% G/L:
$26.50 Last:
1,176 Volume:
$26.50 Open:
GLAXF Latest News
GLAXF Stock Data
$123,941,620,346
2,019,018,428
0.4%
538
N/A
Pharmaceuticals
Healthcare
GB
London
